"but these other countries have said yes to Mesoblast technology last Friday.
Dumb question: Why is MSB - ostensibly the industry leader - letting some intermediary to get between MSB and its revenue opportunity set, in that case?
Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish, page-51
Add to My Watchlist
What is My Watchlist?

